Enanta Pharma Reports Initiation of Phase 2B Trial with Regimen Containing ABT-493
September 10, 2014 at 10:23 AM EDT
Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA) a research and development-focused biotechnology company dedicated to creating small ...